BOSTON (Reuters) - A U.S. appeals court has again found that it is illegal for a dentist to refuse to treat a patient with the AIDS virus. The U.S. 1st Circuit Court of Appeals, in a swift and unanimous, 11-page ruling that was made public Wednesday, said that the use of so-called universal precautions rendered the ris
BOSTON (Reuters) - Most of the people in the United States infected with the AIDS virus are not receiving regular medical treatment, Thursday s New England Journal of Medicine reports. Based on interviews with 2,864 HIV-infected patients in a nationwide survey done in early 1996, the research concludes that the cost of
WILMINGTON, Del., Dec 22 (Reuters) - DuPont Pharmaceuticals said Tuesday that its HIV drug, Sustiva , had been added to the list of medications used by the New York and California AIDS drugs assistance programs. DuPont Pharmaceuticals, the drug unit of the industrial giant DuPont, also said the Texas HIV Medications Ad
WASHINGTON (Reuters) - The U.S. Agriculture Department and the Centers for Disease Control are investigating an outbreak of listeriosis that has killed four people and sickened more than 35 others, a USDA official said Thursday. The official said the illnesses have been reported in eight states: New York, Ohio, Tenness
LONDON, Dec 18 (Reuters) - Britain s Glaxo Wellcome Plc hoped to strengthen its leading position in anti-HIV treatment on Friday with the approval in the United States of a new AIDS drug, Ziagen . Glaxo said the new treatment, which helps block the AIDS virus from rep
LONDON (Reuters) - A small gland that lies just above the heart could be the key to restoring the immune systems of patients with the HIV virus, researchers said Wednesday. Scientists had thought the thymus gland, which produces vital T-cells to fight infections, lost most of its function along with its size as people
BRIDGEWATER, N.J., Dec 16 (Reuters) - Pharmaceutical company Pharmacia & Upjohn (NYSE:PNU - news) on Wednesday said its HIV drug, when used with other HIV drugs, may permit a reduction in dosing with protease inhibitors , and a simpler dosing schedule. Protease inhibitors are potent drugs used to fight HIV inf
WASHINGTON, Dec 3 (Reuters) - A new urine test has found some people have evidence of infection with the AIDS virus in their urine even though their blood shows no sign of infection, researchers said on Thursday. The team at Clinical Reference Laboratory (CRL) said one out of every 1,000 people they tested showed antib
WASHINGTON, Dec 3 (Reuters) - Up to 13 percent of Americans carry genes that could make them succumb to AIDS especially quickly if infected, researchers said on Thursday. The gene variant can make people progress from HIV infection to full-blown AIDS two years sooner than normal, the researchers at the National Cancer
LONDON (Reuters) - Campaigners marked World AIDS Day Tuesday with hundreds of marches and meetings aimed at ramming home the fact that every minute of the year 11 people contract the deadly HIV virus. President Clinton will mark World AIDS Day by announcing increased funding for vaccine research and new money to help f
BEIJING (Reuters) - China is on the verge of a devastating AIDS epidemic, fueled by ignorance about the HIV virus and a rise in intravenous drug use, experts said Monday. Speaking on the eve of World AIDS Day, disease specialists from China and abroad added that the growth of prostitution also threatened to spread HIV
LONDON (Reuters) - An international group devoted to finding an effective AIDS vaccine Thursday launched two research and development partnerships to speed up the search. The International AIDS Vaccine Initiative (IAVI), a New York-based independent non-profit organization, said it was investing $9.1 million in two res
WASHINGTON, Nov 26 (Reuters) - Scientists said on Thursday they had been able to see the changes that let the AIDS virus become resistant to drugs and hope their images can help drug companies develop better ways to attack the virus. Stephen Harrison and colleagues at the Howard Hughes Medical Institute at Harvard Univ
WASHINGTON, Nov 26 (Reuters) - Scientists said on Thursday they had been able to see the changes that let the AIDS virus become resistant to drugs and hope their images can help drug companies develop better ways to attack the virus. Stephen Harrison and colleagues at the Howard Hughes Medical Institute at Harvard Univ
LONDON (Reuters) - Nearly 20 years into the AIDS epidemic and despite promising new drugs and improved prevention, global HIV infections rose 10 percent in 1998 and half of the new cases were in young people under 24. Every minute of the year 11 men, women and children contracted the deadly virus that causes AIDS, brin
BEIJING (Reuters) - China has reached a crossroads in its public health development and faces an uphill battle against communicable diseases, HIV and tobacco, a senior World Health Organization (WHO) official said Monday. In a speech to students and administrators at Beijing Medical University, director-general Gro Har
COLUMBUS, Ohio, Nov 23 (Reuters) - Roxane Laboratories , a Boehringer Ingelheim GmbH company, said Monday that it has received clearance from the U.S. Food and Drug Administration to market a pediatric formulation of the AIDS drug Viramune to treat inf
NEW YORK, Nov 23 (Reuters) - Medical researchers are excited about a new AIDS drug that attacks the HIV virus before it infects healthy cells, but whether the drug ever becomes a practical therapy for patients remains an open question. T-20, which was developed by Durham, N.C.-based Trimeris Inc. (Nasdaq:TRMS - news),
STOCKHOLM (Reuters) - Eighty worried Swedish women had been tested for the AIDS virus by Friday as police hunted a promiscuous carrier of the disease who is believed to have had sex with more than 100 women. Police were focusing their search for the suspect, who they said was probably an Iranian citizen living under a
WASHINGTON (Reuters) - A man with the AIDS virus has volunteered to go off his life-saving drug cocktail in the first formal trial of whether HIV-positive patients can safely quit taking drugs, doctors said Monday. The multi-drug combination has been shown to suppress the virus to nearly undetectable levels, but once p
BEIJING (Reuters) - Police in China have seized 1.5 tons of illegally collected blood and arrested 11 suspected blood dealers, an edition of the Procuratorial Daily seen on Friday said. Police raided a farmer s house in the central province of Hunan and nabbed 13 suspects and 3,000 half-liter (17 ounce) blood bags, the
HAUPPAUGE, N.Y., Oct. 9 (Reuters) - United Biomedical Inc. said Friday it had developed a monoclonal antibody, called B4, that appears able to protect chimpanzees from HIV infection even when the antibody is administered several hours after HIV exposure. The results are based on a six-month study aimed at determining p
Reuters NewMedia - Wednesday October 7, 10:02 pm Eastern Time
Maggie Fox, Health and Science Correspondent
WASHINGTON, Oct 7 (Reuters) - AIDS is no longer one of the 10 leading causes of death in the United States , thanks mostly to multidrug cocktails that keep the virus suppressed, the U.S. government said on Wednesday. The infant mortality rate and the murder rate are also at a new low, the report from the National Cente
SILVER SPRING, Md., Oct 6 (Reuters) - Doctors who advise the U.S. Food and Drug Administration ( FDA ) recommended on Tuesday that the agency approve a drug used against the AIDS virus to fight hepatitis B as well. The drug, Epivir , would be the first pill that people could take for hepatitis B, which infects
VIENNA, Va., Oct 5 (Reuters) - CEL-SCI Corp. (AMEX:HIV - news) said Monday its AIDS vaccine appeared to have given lab mice protection against the deadly HIV virus in the latest series of tests on the efficacy of the vaccine. CEL-SCI, which develops treatments for diseases that attack the immune system, said in a state
WASHINGTON, Oct 2 (Reuters) - A battery of four tests given to children right after they start on HIV drugs can show within a week how well they will respond to the treatment, researchers said on Friday. The tests could potentially save months wasted on drugs that might not work, the researchers said. Dr. Brigitta Muel
WASHINGTON, Oct 1 (Reuters) - Thalidomide, a drug once dreaded for causing severe birth defects but now the source of great hope for treating diseases ranging from cancer to AIDS, hit the market in the United States on Thursday. Celgene Corp., (Nasdaq:CELG - news) which won Food and Drug Administration (
SACRAMENTO, Calif. (Reuters) - California Gov. Pete Wilson signed legislation Wednesday making it a felony to knowingly expose an unaware person to the HIV virus, which causes AIDS through sexual contact. It s a tragedy that so many people contract the HIV virus, Wilson said. An equal tragedy is when HIV-infected indiv
LOS ANGELES, Sept 25 (Reuters) - Drugmakers Agouron (Vancouver:AA.V - news) said on Friday they may be able to help patients with the AIDS virus simplify their complex pill regimens by having them take two daily doses of the protease inhibitor Viracept instead of normal three.
WASHINGTON, Sept 23 (Reuters) - U.S. government researchers said on Wednesday they had found another genetic mutation that could delay the progression of HIV infection into AIDS. They said nearly a third of African-Americans had the mutation, which slows the progression from HIV infection to full-blown AIDS by an avera
ROCKVILLE, Md., Sept 22 (Reuters) - The U.S. Food and Drug Administration ( FDA ) on Tuesday accused Epitope Inc. of paperwork and quality control violations related to manufacturing and distribution of its OraSure HIV testing system. The agency inspected Epitope s Beaverton, Ore. facility in April, and said that the c
RESEARCH TRIANGLE PARK, N.C., Sept 21 (Reuters) - Glaxo Wellcome Inc. said Monday it will make the investigational anti-HIV protease inhibitor Agenerase , or amprenavir , available under an early access program.
CHICAGO, Sept 18 (Reuters) - No solution has been found to a problem on the production line for capsules of the anti-AIDS drug Norvir and supplies will run out within the next month, said manufacturer Abbott Laboratories Inc. (NYSE:ABT - news) on Friday. Some of the roughly 60,000 HIV-infected patients who
NEW YORK (Reuters) - DuPont Pharmaceuticals said Friday it had won U.S. marketing approval for Sustiva , the first once-a-day drug to treat the virus that causes AIDS, predicting it would transform and simplify HIV treatment. Sustiva, a so-called non-nucleoside reverse transcriptase inhibitor, was approved late Thursda
WILMINGTON, Del. (Reuters) - DuPont Pharmaceuticals said Friday the U.S. Food and Drug Administration approved Sustiva , a one-dose-a-day drug to treat the virus that causes AIDS. Although in recent years new HIV drugs have helped reduce the disease from a certain death sentence into a chronic condition, the number of
Reuters NewMedia, Inc.; Thursday September 17, 1998
Mike Cooper
ATLANTA (Reuters) - The percentage of high school students who have had sexual intercourse has declined 11 percent during the 1990s after two decades of increases, federal health officials said Thursday. The Centers for Disease Control and Prevention (CDC) said the percentage of sexually experienced students in grades
WASHINGTON, Sept 14 (Reuters) - More than 100 new drugs are in the works to fight infections by bacteria, viruses and fungi -- but people have to realize no drug is ever a magic bullet against microbes, a drug manufacturer s group said on Monday. The drugs range from new compounds designed to fight superbugs that have
WHITEHOUSE STATION, N.J., Sept 18 (Reuters) - Merck & Co. Inc. said Friday it had discontinued the evaluation of twice-daily dosing regimens of its HIV protease inhibitor, Crixivan , in combination with reverse transcriptase inhibitors. Merck recommends that patients in the twice-daily dosing arms in these stu
Reuters NewMedia, Inc.; Thursday September 10, 1998
WEST CONSHOHOCKEN, Pa. Sept 10 (Reuters) - Pharmaceutical company U.S. Bioscience Inc. on Thursday said its investigational new drug application for lodenosine, a drug to treat patients with the human immunodeficiency virus (HIV), has been cleared by the U.S. Food and Drug Administration to proceed to clinical trials.
Reuters NewMedia, Inc.; Thursday, September 10, 1998
Jim Loney
MIAMI (Reuters) - Society s rejection of transsexuals and transvestites forces them into the sex trade, where they risk becoming victims of violence and AIDS, according to a University of Florida study released Thursday. The study of Miami male transsexuals found they were often rejected by their families at an early a
Reuters NewMedia, Inc.; Wednesday September 9, 1998
SHENZHEN, China (Reuters) - China s first condom vending machines in the southern boomtown of Shenzhen have been such a hit that the experiment will be extended to other cities, the China Daily reported on Wednesday. Each of the 50 machines owned and installed by a Hong Kong sex products company h
Reuters NewMedia, Inc.; Wednesday September 9, 1998
Maggie Fox, Health and Science Correspondent
WASHINGTON (Reuters) - Treatment for drug abusers works, is cheaper and more effective than jail, and should receive more funding, a report released Wednesday shows. The report, timed to coincide with the final budget battles in Congress, is the first long-term look at whether treatment for substance abuse works. It
CAIRO, Sept 6 (Reuters) - Life changed dramatically for the 35-year-old Egyptian when he found out three years ago that he had caught the AIDS virus after having sex with a foreign woman. He was kicked out of his house by his brothers and lost his job as a janitor at a Cairo hotel. My mother and I have nowhere to stay.
PORT-AU-PRINCE, Haiti (Reuters) - A hit U.S. movie that links Haiti with AIDS brought an angry response Friday from government officials, who joined Haitian-Americans in rejecting what they called an unwarranted slur. In the 20th Century Fox summer movie hit How Stella Got Her Groove Back, about a 40-year-old American
NEW YORK, Aug 21 (Reuters) -- About 5% of infants born to HIV-positive women in developing countries become infected with HIV through breastfeeding, according to a report in The Lancet. Based on the study findings, an international team of researchers conclude that the risk of postnatal HIV transmission via breast milk
NEW YORK, Aug 20 (Reuters) -- An increasing number of women are using condoms after tubal sterilization for protection against sexually transmitted diseases (STDs), a study from the Baylor College of Medicine in Houston, Texas, reports. The present investigation reveals the encouraging findings that condom use intentio
LAYTON, Utah, Aug 20 (Reuters) - Medical Discoveries Inc. (MDI), a bio-pharmaceutical company, said on Wednesday its pharmaceutical drug MDI-P had demonstrated potent anti-HIV activity. In a statement, Medical Discoveries said MDI-P had been shown to be effective in killing HIV in cell culture. HIV is the virus that ca
NEW YORK, Aug 19 (Reuters) -- The results of a 2-year trial in prostitutes indicate that vaginal film containing the spermicide nonoxynol 9 is not effective in preventing sexually transmitted diseases (STDs) such as HIV, gonorrhea, or chlamydia infection. The researchers previously released preliminary findings last ye
NEW YORK, Aug 17 (Reuters) -- Extreme fatigue in men who are HIV positive or have AIDS can be substantially alleviated with testosterone injections, according to a study in the August issue of the journal General Hospital Psychiatry. Researchers at the New York State Psychiatric Institute and the College of Physicians
Reuters NewMedia, Inc.; Thursday August 6 7:52 PM EDT
WASHINGTON (Reuters) - Treating prisoners for the virus that causes AIDS, for other sexually transmitted diseases (STDs) and for tuberculosis helps not just the inmates but protects the public, a U.S. government report said Thursday. The joint report by the Department of Justice and the Centers for Disease Control and
Reuters NewMedia, Inc.; Tuesday August 4, 11:21 pm EST
SAN FRANCISCO, Aug 4 (Reuters) - An AIDS patient from New Zealand seeking to test the U.S. ban on immigration by people infected with HIV arrived in San Francisco on Tuesday to claim benefits he earned during 28 years of residence in the city. Despite fears among his lawyers that he would be arrested immediately upon a
Reuters NewMedia, Inc.; Monday August 3, 9:28 pm Eastern Time
WASHINGTON, Aug 3 (Reuters) - New AIDS research should focus on women, new drugs and mother-to-child transmission, the head of the U.S. Office of AIDS Research said on Monday. Neil Nathanson said the course of the disease in the population had changed, and research needed to change with it. AIDS is the plague of the 20
Reuters NewMedia, Inc.; Thursday July 30 5:24 PM EDT
LEWISBURG, Tenn. (Reuters) - A 29-year-old Tennessee woman infected with the AIDS virus took out her anger by having sex with roughly 50 men she picked up in bars, police said Thursday. Pamela Wiser was jailed on two counts of criminal exposure of sex partners with HIV, the virus that causes AIDS, and may face further
Reuters NewMedia, Inc.; Tuesday July 28 7:34 AM EDT
David Finnigan
HOLLYWOOD (Variety) - A new AIDS scare has sent shudders through the adult-film industry, prompting the producers of heterosexual porn to do what many of their gay counterparts began years ago -- making condoms-only sex videos. Leading porn producers have collectively agreed to the all-condoms policy after five porn st
Reuters NewMedia, Inc.; Monday July 20, 10:32 pm EST
Maggie Fox, Health and Science Correspondent
WASHINGTON, July 20 (Reuters) - U.S. AIDS groups that have previously opposed widespread HIV testing reversed their stand on Monday, saying wider testing is one of the best ways to help stem the epidemic. They also said the government and groups like theirs need to step up prevention programs that educate people who ha
Reuters NewMedia, Inc.; Thursday July 30 5:25 PM EDT
CHICAGO (Reuters) - A white mother who discovered her son shared a snorkel with a black child at a suburban swimming pool allegedly coerced authorities to perform an AIDS test on the black child, a lawyer said Thursday. A lawsuit filed in federal court in Chicago by the American Civil Liberties Union named as defendant
Reuters NewMedia, Inc.; Monday July 13, 11:22 am EST
FARMINGDALE, N.Y., July 13 (Reuters) - Enzo Biochem Inc said on Monday that it has initiated Phase I human clinical trials of HGTV43, a genetic antisense-based therapeutic product designed to treat HIV-1 infected individuals. Enzo said that this product has been developed to protect human immune cells against infection
Reuters NewMedia, Inc.; Monday July 13, 9:10 pm EST
WASHINGTON, July 13 (Reuters) - Schizophrenics may have a higher risk than most people of becoming infected with the HIV virus that causes AIDS, researchers said on Monday. A review of dozens of different studies shows that schizophrenics need special protection, psychologist Irving Gottesman of the University of Virgi
ATLANTA (Reuters) - The nation s oldest civil rights organization began its annual convention Saturday with its leader promising to go into the streets to highlight the skyrocketing rate of AIDS among blacks. Kweisi Mfume, the president of the National Association for the Advancement of Colored People, said he would as
Reuters NewMedia, Inc.; Friday July 10, 6:34 pm EST
Delphine Dewulf
TORONTO, July 10 (Reuters) - A five-year-old girl who is HIV-positive and was initially refused a visa to visit Canada with her adoptive parents, has finally been allowed to enter the country with her family for a six month visit, Canadian immigration officials said on Friday. The child, Nikki, was adopted in
Reuters NewMedia, Inc.; Wednesday July 8, 8:55 pm EST
BOSTON, July 8 (Reuters) - Yearlong use of an anti-AIDS drug can help prevent liver damage in people suffering from hepatitis B, according to a study by a team of doctors in Hong Kong , Taiwan and Singapore .
GENEVA (Reuters) - U.S. drugs group Abbott Laboratories Inc. presented preliminary data on its second-generation protease inhibitor ABT-378 at the 12th World AIDS conference, saying the drug was well-tolerated and potent. Abbott is combining the drug with a small amount of its existing protease inhibitor
Reuters NewMedia, Inc.; Friday July 3 11:33 PM EDT
Patricia Reaney
GENEVA (Reuters) - The 12th World AIDS Conference ended on Friday with a call to arms, speakers warning that the war against the pandemic that will afflict 40 million people by the millennium is far from over. As a counter added up the number of people infected with the HIV virus around the world -- one every five seco
Reuters NewMedia, Inc.; Thursday July 2 9:10 AM EDT
Jonathan Birt
GENEVA (Reuters) - Three new lines of potential defense against the virus that causes AIDS were set out on Thursday by Dr. Robert Gallo, the pioneering American researcher who helped discover the HIV virus. Gallo said work should concentrate on methods of blocking the virus from entering healthy cells, moving on from c
Reuters NewMedia, Inc.; Thursday July 2, 7:32 pm EST
Mark Egan
LOS ANGELES, July 2 (Reuters) - Shares of Gilead Sciences Inc. fell more than 17 percent on Thursday after several analysts cut their ratings on the stock amid concerns that the toxicity of the company s HIV drug may hurt potential sales. Foster City, Calif.-based Gilead closed $5 lower at $25.375in active trading on t
Reuters NewMedia, Inc.; Wednesday July 1, 4:35 pm EST
WASHINGTON, July 1 (Reuters) - A first stab at using gene therapy to treat the HIV virus that causes AIDS looks hopeful, scientists reported on Wednesday. They said very early Phase I trials for safety in twins showed the treatment was safe and well-tolerated. Gene therapy has never been shown to truly work in people.
EMERYVILLE, Calif., July 1 (Reuters) - Biotechnology firm Chiron Corp. (CHIR - news) said Wednesday that its HIV treatment drug Proleukin has been shown to increase the CD4+ cell counts of patients infected with HIV. The company said that the results came from a Phase II study by the French National Agency on AIDS Rese
FOSTER CITY, Calif., July 1 (Reuters) - Gilead Sciences Inc. said on Wednesday that its Preveon drug when used with other drugs showed a decrease in levels of HIV genetic material when tested in Phase II/III clinical trials. In data presented to the 12th World AIDS Conference in Geneva, once-daily treatment with Preveo
GENEVA (Reuters) - American researchers said Wednesday they were looking at the possibility that some individuals have a natural immunity that protects them from the HIV virus. Although scientists at the University of California San Francisco AIDS Research Institute stressed it was early, they said the theory could pla
Reuters NewMedia, Inc.; Wednesday July 1 10:56 AM EDT
Patricia Reaney
GENEVA (Reuters) - An American doctor who reported the first case of transmission of a strain of the HIV virus that is resistant to the most potent drugs said it was a important warning sign but no reason to panic. Dr Frederick Hecht of the University of California and San Francisco General Hospital told the 12th World
Reuters NewMedia, Inc.; Tuesday June 30 3:07 PM EDT
Patricia Reaney
GENEVA (Reuters) - Leading AIDS experts held out hope for a vaccine within a decade and warned that even the most potent triple drug combinations are not eliminating the HIV virus in infected patients. Drug cocktails including the latest protease inhibitors can reduce the virus that causes AIDS to undetectable levels i
Reuters NewMedia, Inc.; Tuesday June 30, 7:33 pm EST
NEW YORK, June 30 (Reuters) - Vertex Pharmaceuticasl (VRTX - news) said Tuesday that patients with HIV who received a combination of the investigational drugs Ziagen and Agenerase showed reduced virus after 48 weeks of treatment according to preliminary data from a small Phase II s
Reuters NewMedia, Inc.; Tuesday June 30, 9:36 am EST
NEW YORK, June 30 (Reuters) - Laboratory Corp. of America Holdings and VIRCO, a private Belgian biotechnology company, on Tuesday said their two new diagnostic tests for HIV, Antivirogram and VircoGEN, will be available in the U.S. for commercial use on July 20. The testing procedures will enable physicians to evaluate
Reuters NewMedia, Inc.; Monday June 29 3:06 PM EDT
Patricia Reaney
GENEVA (Reuters) - New research into how the HIV virus infects healthy cells could help explain why some people develop AIDS within months while others live for years without any symptoms, scientists said on Monday. The virus invades the body by entering host cells, using the cell s machinery to replicate and produce n
Reuters NewMedia, Inc.; Sunday June 28 1:18 PM EDT
Patricia Reaney
GENEVA (Reuters) - A new global plan to speed up AIDS vaccine development was launched at the start of the 12th World AIDS conference Sunday. The International AIDS Vaccine Initiative (IAVI), an independent non-profit scientific organization, released its scientific blueprint designed to advance progress in preventativ
Reuters NewMedia, Inc.; Sunday, June 28, 1998 06:43:00 PM
Greg Calhoun
GENEVA, Switzerland (Reuters) - The 12th Annual World AIDS Conference opening here Sunday will focus on bridging the gap between rich nations where advances against the disease are being made and the developing world where infection and death rates are still advancing rapidly. The essential message of the Geneva m
Reuters NewMedia, Inc.; Sunday June 28 2:13 AM EDT
Jonathan Birt
GENEVA (Reuters) - The 12th World Aids Conference which opens in Geneva on Sunday will be a much more sober event than its predecessor in Vancouver two years ago. Talk of dramatic breakthroughs in treatment of HIV and AIDS in Canada has given way to realization that prospects of eradicating the disease remain an elusiv
Reuters NewMedia, Inc.; Friday June 26 2:00 AM EDT
James Vicini
WASHINGTON (Reuters) - A divided Supreme Court has ruled that the law that protects the disabled from discrimination covers people who have the virus that causes AIDS, even if they have none of the disease s symptoms. The 5-4 decision was the high court s first AIDS-related ruling and was only the second time it decide
Reuters NewMedia, Inc.; Thursday June 25, 2:52 am EST
Chris Johnson
BANGKOK, June 25 (Reuters) - Asia s economic crisis is hampering the fight against AIDS and will increase the spread of HIV in what is already the world s second most affected region, regional health officials said on Thursday. Despite promises that the battle against the epidemic would not be hit by recession, governm
Reuters NewMedia, Inc.; Tuesday June 23 7:53 PM EDT
SOUTH SAN FRANCISCO, Calif. (Reuters) - Volunteers in the first large-scale test of a vaccine against the virus that causes AIDS received their first inoculations Tuesday, the company that developed the serum said. VaxGen , a privately held South San Francisco biotechnology company that developed the vaccine, known as
Reuters NewMedia, Inc.; Saturday June 20 2:28 PM EDT
ALBANY, N.Y. (Reuters) - New York state is poised to establish the nation s first central registry of people who are HIV-positive, after the proposed measure passed the state legislature. Under the legislation, anyone testing positive for HIV, the virus that causes AIDS, will be reported to the state Health Department.
Reuters NewMedia, Inc.; Thursday June 18, 10:56 pm EST
Maggie Fox, Health and Science Correspondent
WASHINGTON, June 18 (Reuters) - AIDS education and self-help programs can help even the hardest-to-reach groups change their behavior for the better and prevent the spread of AIDS, researchers said on Thursday. A study at 37 clinics across the United States shows that no group is too hopeless to help, the researchers,
Reuters NewMedia, Inc.; Tuesday June 16 5:28 PM EDT
CHICAGO (Reuters) - A U.S. study said to be the most detailed look yet at young people coming of age in the AIDS era found a dramatic drop in infection rates of the disease among white men, researchers said Tuesday. But the study also found heterosexual transmission of the disease, Acquired Immune Deficiency Syndrome,
Reuters NewMedia, Inc.; Thursday June 11, 4:38 pm EST
LA JOLLA, Calif., June 11 (Reuters) - Immune Response Corp said Thursday it signed a pact with Agouron Pharmaceuticals for final development and commercialization of HIV treatment REMUNE worth up to $77 million to Immune Response over two years. REMUNE is an immune-based therapy for the treatment of HIV infection which
Reuters NewMedia, Inc.; Thursday June 11, 11:14 am EST
WILMINGTON, Del., June 11 (Reuters) - DuPont Merck Pharmaceutical Co. said Thursday had it submitted a new drug application to the U.S. Food and Drug Administration for its anti-HIV treatment Sustiva . The FDA has designated Sustiva as a fast-track product, which means the regulatory agency will expedite the rev
Reuters NewMedia, Inc.; Wednesday June 17 11:34 PM EDT
Maggie Fox, Health and Science Correspondent
WASHINGTON (Reuters) - Researchers said Wednesday they had gotten their first good look at the physical structure of a key protein used by the AIDS virus, and found it is a viral Houdini that shifts shape to evade the body s defenses. They managed to image the crystalline structure of the gp120 protein the virus uses t
WASHINGTON (Reuters) - AIDS activists Thursday used the body of a dead colleague to protest the Clinton administration s policies on the disease. Steve Michael, who died of AIDS May 25 at the age of 42, was given an open casket funeral in front of the White House, in accordance with his dying wish. He wanted a last sta
Reuters NewMedia, Inc.; Thursday June 4 2:07 AM EDT
Maggie Fox, Health and Science Correspondent
WASHINGTON (Reuters) - The U.S. Food and Drug Administration ( FDA ) gave the go-ahead Wednesday for large-scale tests of a vaccine against the AIDS virus -- the first vaccine to make it this far in testing. But many AIDS experts were skeptical about whether the vaccine, developed by California-based
Reuters NewMedia, Inc.; Wednesday June 3, 1:52 pm EST
Nicholas Moss
LONDON, June 3 (Reuters) - A London-based insurer is targeting homosexual men as a niche market with what it says is a first: an income protection policy which includes cover for HIV or AIDS. The policy, underwritten at Lloyd s of London, offers cover for gay men contracting HIV, AIDS or sexually-transmitted diseases,
Reuters NewMedia, Inc.; Wednesday June 3, 11:02 am EST
SOUTH SAN FRANCISCO, Calif., June 3 (Reuters) - The U.S. Food and Drug Administration has approved Phase III clinical trials for VaxGen Inc. s AIDSVAX vaccine against HIV, the virus that causes AIDS, the company said Wednesday. VaxGen said it will be the first time an HIV vaccine has been evaluated in a large-scale stu
Reuters NewMedia, Inc.; Sunday May 31, 5:00 pm EST
STANFORD, Calif., May 31 (Reuters) - The AIDS virus has the potential to outsmart virtually all the drug treatments now approved in the United States to treat it, according to a study released on Sunday. There is a problem with drug resistance, and we can t fool ourselves, said Stanford University s Dr. Robert Shafer,
WASHINGTON, May 8 (Reuters) - A gene mutation that protects some people from infection with the HIV virus that causes AIDS may have protected people hundreds of years ago from plague, researchers said on Friday. Scientists at the National Cancer Institute (NCI) think it s a reasonable explanation of why up to 15 percen
Reuters NewMedia, Inc.; Wednesday May 6, 3:57 pm EST
GAITHERSBURG, Md., May 6 (Reuters) - Unimed Pharmaceuticals Inc. said Wednesday that a U.S. Food and Drug Administration advisory panel has requested additional information about the company s Cryptaz diarrhea treatment before it decides whether to recommend the drug to the FDA for marketing clearance. In a stateme
Reuters NewMedia, Inc.; Tuesday May 5, 11:15 pm EST
WASHINGTON, May 5 (Reuters) - More than 40 percent of Americans infected with HIV do not take their drugs as directed, according to a survey published on Tuesday. The survey found that 43 percent of HIV patients polled admitted that they did not take all of their drugs as prescribed -- even though multi-drug cocktails
LOS ANGELES (Reuters) - Los Angeles television stations engaged in agonizing soul-searching Friday after preempting afternoon talk and children s shows a day earlier to show a man kill himself with a shotgun on a freeway. Two of the six stations that broadcast the scene live kept their cameras rolling close-up even as
Reuters NewMedia, Inc.; Thursday April 30, 10:39 am EST
FARMINGDALE, N.Y., April 30 (Reuters) - Enzo Biochem Inc. Thursday said it received a phase one grant from the National Institutes of Health to develop a drug to treat HIV patients in a new way. The grant may last for up to six months and could lead to a larger phase two grant if early trials were successful, a company
Reuters NewMedia, Inc.; Tuesday April 28, 2:27 pm Eastern Time
TROY, Mich., April 28 (Reuters) - R.P. Scherer Corp. said on Tuesday that it signed an exclusive agreement to make softgels for a Roche Holding Ltd (ROCZg.S) affiliate F. Hoffmann-La Roche drug used to treat HIV-infected patients. Scherer has been making soft gelatin, or softgel, capsules for Roche filled with the prot
Reuters NewMedia, Inc.; Tuesday April 28, 9:54 pm EST
BURLINGTON, N.C., April 28 (Reuters) - Laboratory Corp. of America) Holdings said Tuesday that it has an exclusive partnership with VIRCO, a Belgian-based biotechnology company, to offer blood analysis tests that will tell doctors and their HIV positive patients which drugs are likely to be effective against the indivi
Reuters NewMedia, Inc.; Thursday April 16, 10:34 pm EST
Maggie Fox, Health and Science Correspondent
WASHINGTON, April 16 (Reuters) - The HIV virus that causes AIDS may head straight for the gut early on in infection -- which could mean that research into ways to fight it has been looking in the wrong place, researchers said on Thursday. Tests on monkeys show that SIV, their version of HIV, destroys immune cells in th
Reuters NewMedia, Inc.; Thursday April 9, 6:19 pm EST
Michael Kahn
WASHINGTON, April 9 (Reuters) - Improved techniques for measuring the body s immune response are giving researchers insights that could help them in the fight to develop vaccines against HIV and cancer, scientists said on Thursday. While making advances in learning about viruses and other invaders like bacteria, doctor
Reuters NewMedia, Inc.; Tuesday March 31 1:57 AM EST
James Vicini
WASHINGTON (Reuters) - The U.S. Supreme Court heard arguments on whether the law barring discrimination based on disability applies to people who have the virus that causes AIDS, but have no symptoms of the disease. It was the first AIDS-related case considered by the court and the first time it has taken up the eight-
Reuters NewMedia, Inc.; Monday March 30, 8:25 pm EST
WASHINGTON, March 30 (Reuters) - An unidentified chemical produced by pregnant women appears to help block infection by the HIV virus that causes AIDS, researchers reported on Monday. Dr. Robert Gallo of the Institute of Human Virology in Baltimore, who helped discover HIV, said he and colleagues were backing away from
Reuters NewMedia, Inc.; Friday March 27 6:59 PM EST
Patrick Connole
WASHINGTON (Reuters) - A coalition of House Democrats and health experts Friday urged the Clinton administration to lift a ban on federal funding for needle exchange programs when a moratorium ends next week. Last year, Congress imposed a ban on using federal monies for such exchanges until March 31. After March 31, fe
Reuters NewMedia, Inc.; Friday March 27 1:53 AM EST
Mike Cooper
ATLANTA (Reuters) - Federal health officials said Thursday that expanded use of rapid tests for the AIDS virus could detect thousands more cases of HIV infection every year. The Centers for Disease Control and Prevention (CDC) said the tests now commonly used, while more precise, can take weeks to process and that many
Reuters NewMedia, Inc.; Thursday March 26, 11:04 pm EST
Mark Weinraub
WASHINGTON, March 26 (Reuters) - The human immune system has cells that can hold down levels of the AIDS virus in blood and may provide a model for a possible vaccine, researchers confirmed on Thursday. The more of these cells, known as cytotoxic T-lymphocytes (CTLs), there are in the blood, the lower the viral load or
Reuters NewMedia, Inc.; Wednesday March 25, 8:37 pm EST
Leslie Gevirtz
BOSTON, March 25 (Reuters) - The powerful three-drug combination known as the AIDS cocktail dramatically cuts the rate of death and disease for those with HIV infections, a new study finds. U.S. researchers report in Thursday s New England Journal of Medicine that even among those with the most severely compromised imm
Reuters NewMedia, Inc.; Wednesday March 25 6:40 AM EST
WASHINGTON (Reuters) - Most U.S. teenagers will have had sex by the time they are 18, and nearly half say they have felt pressured into sexual relationships, a survey released Wednesday found. The survey of 650 13 to 18-year-olds found that 47 percent said they had done something sexual, or felt pressure to do somethin
Reuters NewMedia, Inc.; Tuesday March 24, 9:00 pm EST
CHICAGO, March 24 (Reuters) - The U.S. unit of Japan s largest transportation firm, Nippon Express (9062.T), has been sued in federal court by an employee with AIDS who alleged the company harassed him, officials said on Tuesday. The lawsuit filed last week on behalf of ex-employee Richard McCullough by the U.S. Equal
Reuters NewMedia, Inc.; Tuesday March 24, 7:12 pm EST
CHICAGO, March 24 (Reuters) - The drug nevirapine , taken in combination with two others, lowered the AIDS virus in the blood of half of HIV-infected patients tested to undetectable levels after one year, researchers said on Tuesday. Nevirapine, which is sold under the brand name
Reuters NewMedia, Inc.; Monday March 23, 10:51 pm EST
TOKYO, March 24 (Reuters) - Nippon Roche KK, a Japan unit of Roche Holding AG (OTC BB:ROHHY - news; ROCZg.S), said on Tuesday it had began sales of anti-HIV drug Viracept in most of Japan. Viracept was developed jointly by Japan Tobacco Inc (JT) (2914.T) and Agouron Pharma
Reuters NewMedia, Inc.; Wednesday March 18, 5:35 pm EST
Gilbert Le Gras
TORONTO, March 18 (Reuters) - The hope that white blood cells could one day be marshalled to combat AIDS has been dashed by a top researcher who helped discover the HIV virus. White blood cells, it turns out, can also become infected and die -- a setback in the battle against the disease. We now know they re infectable
Reuters NewMedia, Inc.; Wednesday March 18, 10:04 am EST
LONDON, March 18 (Reuters) - British drugs giant Glaxo Wellcome Plc (quote from Yahoo! UK & Ireland : GLXO.L) said on Wednesday it had been given approval by the European Commission to market Combivir in all 15 countries in the Europ
Reuters NewMedia, Inc.; Tuesday March 17, 8:48 pm EST
MENLO PARK, Calif., March 17 (Reuters) - African Americans are twice as worried about AIDS as the rest of the country, and most say the government is not doing enough to fight the disease in their communities, said a survey released on Tuesday. Blacks make up just 12 percent of the U.S. population, but accounted for so
Reuters NewMedia, Inc.; Tuesday March 10 10:40 PM EST
Mike Cooper
FORT BENNING, Ga. (Reuters) - A married U.S. Army soldier infected with the virus that causes AIDS pleaded guilty at his court-martial Tuesday to charges he had unprotected sex with seven women without disclosing his medical condition. Army Spc. Raymond Humphries pleaded guilty to seven counts of aggravated assault, ei
TOKYO, March 6 (Reuters) - Japan Tobacco Inc (JT) (2914.T) said on Friday that the Health Ministry has approved the sale of JT s anti-HIV drug Viracept in Japan. A company spokesman said further details would be announced at 11 a.m. (0200 GMT). In May 1997, JT applied for government approval to import Vir
ATLANTA, March 5 (Reuters) - AIDS cases among American Indians and the indigenous people of Alaska have leveled off, U.S. health officials said on Thursday. The federal Centers for Disease Control and Prevention said 1,783 AIDS cases had occurred among American Indians and native Alaskans since the epidemic began. AID
WASHINGTON, March 5 (Reuters) - The U.S. Agency for International Development (USAID) said on Thursday it would spend most of a $50 million budget windfall on malaria, tuberculosis and fighting drug-resistant superbugs . Better surveillance networks aimed at nipping epidemics ranging from measles to Ebola in the bud wo
BUFFALO GROVE, Ill., March 5 (Reuters) - Unimed Pharmaceuticals Inc said Thursday the U.S. Food and Drug Administration approved a priority review for its NTZ drug which treats cryptosporidial diarrhea in people with HIV. An FDA priority review ensures that a new drug application will be completely reviewed and acted u
PHILADELPHIA, March 5 (Reuters) - Women treated for HIV-infection at U.S. outpatient clinics had an improved overall survival rate if those medical facilities were experienced at treating AIDS, researchers said on Thursday. A study of 887 women covered under Medicaid found that 71 percent of those patients who sought t
WASHINGTON, March 5 (Reuters) - AIDS groups welcomed an announcement on Thursday by drugs giant Glaxo-Wellcome (quote from Yahoo! UK & Ireland : GLXO.L) that it would lower the prices of its mainstay HIV drugs AZT and
Reuters NewMedia, Inc.; Thursday February 19, 10:44 pm EST
LONDON, Feb 20 (Reuters) - Canadian and American researchers said on Friday that giving the drug ritonavir to patients with severe HIV can stave off their progression to full-blown AIDS. When ritonavir, made by Abbott Laboratories [NYSE:ABT - news] Inc, was taken along with existing treatments during an int
Reuters NewMedia, Inc.; Wednesday February 18 5:05 PM EST
Maggie Fox, Health and Science Correspondent
WASHINGTON (Reuters) - A simplified regimen of the drug AZT can stop mother-to-child transmission of the HIV virus that causes AIDS and should quickly be adopted in poor countries, researchers said on Wednesday. Long-awaited results from a trial in Thailand showed the cheaper and sim
Reuters NewMedia, Inc.; Wednesday February 18 11:42 AM EST
JERUSALEM (Reuters) - The Israeli Health Ministry said it would try to persuade an HIV-positive prostitute, aged about 70, to stop her work. AIDS activists in contact with the prostitute say she has intercourse with six to 10 customers a day, charges only 10 shekels ($2.80) and does not demand that they wear condoms.
Reuters NewMedia, Inc.; Monday February 16 11:35 AM EST
NEW YORK (Reuters) -- Counseling patients on the importance of reducing any risk behaviors for HIV infection should be a big part of postexposure preventive treatment. Although it is not clear that postexposure preventive treatment after sexual contact is effective, two San Francisco, California-based physicians point
Reuters NewMedia, Inc.; Sunday February 15, 4:23 pm EST
Maggie Fox, Health and Science Correspondent
PHILADELPHIA, Feb 15 (Reuters) - Leading U.S. AIDS researchers appealed for help from across the scientific community on Sunday in finding a vaccine against the HIV virus. Peter Kim of the Massachusetts Institute of Technology said vaccine research needed all the help it could get. With more than 40 vaccines in trials,
Reuters NewMedia, Inc.; Friday February 13 3:05 PM EST
WASHINGTON (Reuters) - President Clinton Friday presided over the swearing-in ceremony of Dr. David Satcher as U.S. Surgeon General, a post that has been vacant for three years. The Senate Tuesday easily confirmed Satcher, ending a nasty confirmation battle that focused on the politics of AIDS and abortion. The 63-35 v
Reuters NewMedia, Inc.; Wednesday February 11 6:33 PM EST
NEW YORK (Reuters) -- The results of lab tests conducted in physicians office laboratories (POLs) are three times more likely to be inaccurate than tests sent to licensed labs, according to a report this week in The Journal of the American Medical Association (JAMA). Patients should be aware that preliminary findings s
Reuters NewMedia, Inc.; Wednesday February 11 1:57 AM EST
Joanne Kenen
WASHINGTON (Reuters) - The Senate easily confirmed President Clinton s nomination of Dr. David Satcher as U.S. Surgeon General, ending a nasty confirmation battle that focused on the politics of AIDS and abortion. The 63-35 vote filled a three-year vacancy in the post often called America s family doctor. No one is bet
Reuters NewMedia, Inc.; Sunday February 8 11:45 PM EST
BOSTON (Reuters) - A study due to be published Monday found that three out of four women infected with the AIDS virus told their sexual partners while about half the number of infected men disclosed their affliction. Led by Brown University s Dr. Michael Stein, researchers at two New England city hospitals found that o
Reuters NewMedia, Inc.; Thursday February 5, 8:54 am EST
CHICAGO, Feb 5 (Reuters) - Glaxo-Wellcome s experimental drug abacavir can work in patients who have developed resistance to older drugs in the same class such as AZT and 3TC , researchers said.
Reuters NewMedia, Inc.; Thursday February 5, 9:56 am EST
CHICAGO, Feb 5 (Reuters) - DuPont Merck s experimental new drug Sustiva , known also as efavirenz , worked to suppress HIV in patients who got it along with one and with two other drugs, researchers told an AIDS medical conference. Sustiva is one of a new class of drugs called no
Reuters NewMedia, Inc.; Thursday February 5, 11:53 pm EST
Maggie Fox, Health and Science Correspondent
CHICAGO, Feb 6 (Reuters) - A 35-year-old drug used mostly to treat cancer has shown astonishing results in a few AIDS patients and may offer the best hope yet to people who are diagnosed with HIV infection early, doctors say. The drug is hydroxyurea and three patients who have taken it in combination with other anti-HI
Reuters NewMedia, Inc.; Thursday February 5, 7:33 pm EST
CHICAGO, Feb 5 (Reuters) - New HIV drugs are responsible for saving lives in New York, researchers told a retrovirus conference on Thursday. They said protease inhibitors , a fairly new class of HIV drugs, were clearly responsible for an already reported decline in AIDS deaths in New York City. Mary Ann Chiasson of the
Reuters NewMedia, Inc.; Thursday February 5, 7:49 pm EST
CHICAGO, Feb 5 (Reuters) - Two studies released on Thursday show it is dangerous to cut back on the cocktails of drugs that are working to suppress the HIV virus that causes AIDS. Cocktails of three, four, and up to six different drugs have been shown to keep the virus down to near-unmeasurable levels, and keep infecte
Reuters NewMedia, Inc.; Thursday February 5, 6:33 pm EST
CHICAGO, Feb 5 (Reuters) - Gilead Sciences Inc s experimental drug PMPA is safe and seems to work against the HIV virus that causes AIDS, researchers reported Thursday. They told a conference on HIV that tests of PMPA, a new drug known as a nucleotide analogue, showed the pill taken once a day decreased the amount of v
Reuters NewMedia, Inc.; Thursday February 5, 6:59 pm EST
CHICAGO, Feb 5 (Reuters) - A new treatment against the AIDS virus using a decades-old cancer drug has kept one man healthy for more than a year after he stopped taking the drugs, researchers said on Thursday. We were quite excited about this, Dr. Franco Lori, co-director of the Research Institute for Genetic and Human
Reuters NewMedia, Inc.; Thursday February 5, 8:09 pm EST
SEATTLE, Feb 5 (Reuters) - Immunex Corp said Thursday laboratory studies suggest its Leukine drug may have a role in treating HIV patients by blocking the entry of the HIV virus into human macrophages. Macrophages are the immune system cells suspected of harboring the last vestiges of HIV infection that remain after ye
Reuters NewMedia, Inc.; Thursday February 5, 7:10 pm EST
CHICAGO, Feb 5 (Reuters) - A new, experimental drug called FTC can work by itself to knock the HIV virus back to low levels, researchers told a conference on Thursday. The drug, made by Triangle Pharmaceuticals (VIRS - news) in Durham, North Carolina, worked both in low, twice-a-day doses and in one high daily dose in
Reuters NewMedia, Inc.; Thursday February 5, 2:54 pm EST
WEST CONSHOHOCKEN, Pa., Feb 5 (Reuters) - U.S. Bioscience Inc said Thursday the Phase I trial of its lodenosine (FddA) drug showed it anti-HIV activity, defined as a reduction in HIV viral load. The company said in a statement the anti-HIV drug showed the activity even in patients who had failed other AIDS antiretrovir
Reuters NewMedia, Inc.; Thursday February 5, 9:26 am EST
CHICAGO, Feb 5 (Reuters) - A four-drug combination of drugs works powerfully both in patients who have never been treated for HIV before and in those who have tried simpler regimens, researchers said. The cocktail, tested in 57 volunteers, included the NNRTI nevirapine , which is sold as
Reuters NewMedia, Inc.; Wednesday February 4, 4:58 pm EST
Maggie Fox, Health and Science Correspondent
CHICAGO, Feb 4 (Reuters) - Strong triple-drug cocktails that show near-miraculous results in many adults in controlling the AIDS virus, are working in children too, researchers said on Wednesday. Children are not normally given cocktail treatments, partly because of fears the toxic drugs will make them too ill, partly
Reuters NewMedia, Inc.; Wednesday February 4, 9:09 pm EST
Maggie Fox, Health and Science Correspondent
CHICAGO, Feb 4 (Reuters) - It is a bewildering array of drugs and classes of drugs, with confusing names like protease inhibitors and reverse transcriptase inhibitors. Doctors are still trying to figure out which drugs to give their HIV-infected patients, how many and at what doses. Dozens of studies being presente
Reuters NewMedia, Inc.; Wednesday February 4, 10:15 pm EST
Maggie Fox, Health and Science Correspondent
CHICAGO, Feb 4 (Reuters) - Scientists said on Wednesday they are intrigued by a series of studies on unusual fat deposits -- given nicknames like the buffalo hump and protease paunch -- developing in some people taking drug cocktails to fight HIV infection. Ranging from buffalo humps on the upper back under the neck to
Reuters NewMedia, Inc.; Wednesday February 4, 8:24 pm EST
BELTSVILLE, Md., Feb 4 (Reuters) - Digene Corp said Wednesday data preliminary study results from its new HIV RNA test show the test can detect as few as 100 copies of the HIV virus per milliliter of blood. The results were presented at the fifth conference on Retroviruses and Opportunistic Infections in Chicago, Ill,
Reuters NewMedia, Inc.; Wednesday February 4, 4:58 pm EST
Maggie Fox, Health and Science Correspondent
CHICAGO, Feb 4 (Reuters) - Strong triple-drug cocktails that show near-miraculous results in many adults in controlling the AIDS virus, are working in children too, researchers said on Wednesday. Children are not normally given cocktail treatments, partly because of fears the toxic drugs will make them too ill, partly
CHICAGO, Feb 3 (Reuters) - Despite powerful new drug cocktail treatments, the HIV virus that causes AIDS is proving hard to ferret out, hiding in resting immune system cells, in the testicles and perhaps elsewhere in the body, researchers said on Tuesday. But they told a conference on HIV they were rolling out new weap
Reuters NewMedia, Inc.; Tuesday February 3 5:11 PM EST
Maggie Fox, Health and Science Correspondent
CHICAGO (Reuters) - Researchers said Tuesday they had traced the very first case of HIV infection to a man living in what was then the Belgian Congo in 1959. They say their finding shows that the HIV virus that causes AIDS first showed up in people 10 to 20 years earlier than has previously been estimated. The man was
Reuters NewMedia, Inc.; Monday February 2, 5:46 pm EST
NEW YORK, Feb 2 (Reuters) - Pharmacia & Upjohn Inc said on Monday that it halted clinical trials for Rescriptor because of statistically significant favorable clinical trial results. Rescriptor is a non-nucleoside HIV-1 reverse transcriptase inhibitor indicated for the treatment of HIV-1 infection combined
Reuters NewMedia, Inc.; Monday February 2, 7:07 pm EST
Maggie Fox, Health and Science Correspondent
CHICAGO, Feb 2 (Reuters) - The United States and other industrialized nations are in danger of losing track of the AIDS epidemic, partly because new drugs work so well preventing progression to full-blown AIDS, experts said on Monday. The numbers of new AIDS cases are way down, but more and more it is becoming a diseas
Reuters NewMedia, Inc.; Monday February 2, 8:28 pm EST
Maggie Fox, Health and Science Correspondent
CHICAGO, Feb 2 (Reuters) - Simple, and seemingly obvious, programs can help stop the spread of the virus that causes AIDS, researchers said on Monday. Eighteen years into the AIDS epidemic, people are still embarrassed to talk about ways to protect themselves from the virus, and are even avoiding life-saving treatment,
Reuters NewMedia, Inc.; Monday February 2 2:08 PM EST
Maggie Fox, Health and Science Correspondent
CHICAGO (Reuters) - With development of a vaccine years away, AIDS experts say it is vital to fine-tune the combinations of drugs that keep the virus at bay. Speakers opening a scientific meeting on HIV research all agreed the most important single challenge in AIDS is the development of a vaccine, Dr. Douglas Richman
Reuters NewMedia, Inc.; Sunday February 1 8:38 PM EST
Maggie Fox, Health and Science Correspondent
CHICAGO (Reuters) - Ignorance of how the immune system works is blocking any quick breakthrough in developing a vaccine against the virus that causes AIDS, one of the world s top researchers said on Sunday. Dr. David Baltimore of the California Institute of Technology in Pasadena predicted development of an AIDS vaccin
Reuters NewMedia, Inc.; Wednesday January 28, 9:48 pm EST
Maggie Fox, Health and Science Correspondent
WASHINGTON, Jan 28 (Reuters) - A gene therapy approach known as antisense may work against the virus that causes AIDS, as well as fight cancer and heart disease, three teams of researchers reported on Wednesday. The technique, which uses mirror-image molecules to interfere with undesirable genes, is gaining popularity
Reuters NewMedia, Inc.; Tuesday January 27 3:50 PM EST
CHICAGO (Reuters) - A gene mutation present in about one in six white people slows the progress of AIDS in many HIV-infected newborns, raising the possibility of treatments exploiting the phenomenon, French researchers said Tuesday. The researchers studied 512 white children born to mothers infected with the virus that
Reuters NewMedia, Inc.; Monday January 26, 11:11 am EST
DURHAM, N.C., Jan 26 (Reuters) - Triangle Pharmaceuticals Inc said FTC, an antiviral nucleoside analogue and a member of the same series as 3TC , significantly reduced plasma HIV-1 RNA viral load in Phase I/II clinical trials. Triangle, a pharmaceutical research and development company, said in a press release that pre
Reuters NewMedia, Inc.; Friday January 23 3:00 PM EST
Dan Thomas
SAN PEDRO SULA, Honduras (Reuters) - To many Central American men, soccer is not a matter of life and death -- it is far more important than that. In 1969, amid an escalating border dispute between Honduras and El Salvador , a tense World Cup qualifying match sparked a war between the two neighbors in
Reuters NewMedia, Inc.; Friday January 23, 7:13 pm EST
WASHINGTON, Jan 23 (Reuters) - AIDS researchers said on Friday they were trying a new approach against the deadly virus by combining a vaccine with the triple-drug therapy that has been proved to suppress HIV. The University of Pennsylvania researchers said they hoped a vaccine would work better in people who had the v
Reuters NewMedia, Inc.; Thursday January 22 5:17 PM EST
ORLANDO, Fla. (Reuters) - A Florida judge has ordered a man infected with the virus that causes AIDS to get written consent from partners before engaging in sex, court officials said Thursday. They said Orange County Judge Deb Blechman sentenced Jerrime Day, 20, to one year s probation Wednesday for having sex with an
Reuters NewMedia, Inc.; Thursday January 22 3:50 PM EST
Mike Cooper
ATLANTA (Reuters) - AIDS cases have risen more rapidly among people over 50 than among younger adults, federal health officials said Thursday. The Centers for Disease Control and Prevention (CDC) said the number of new AIDS cases among people aged 50 and above rose 22 percent between 1991 and 1996, compared with a 9 pe
Reuters NewMedia, Inc.; Wednesday January 14, 5:57 pm EST
WASHINGTON, Jan 14 (Reuters) - Researchers funded by the U.S. government said Wednesday they were starting trials of three new vaccines against the HIV virus that causes AIDS. The trials, being run in St. Louis, Nashville, Seattle, Birmingham, Baltimore and Rochester, are funded by the National Institute of Allergy and
Reuters NewMedia, Inc.; Tuesday January 13, 9:13 am EST
WILMINGTON, Del., Jan 13 (Reuters) - Signal Pharmaceuticals Inc said Tuesday it formed a three year deal with a potential value of $25 million with DuPont Merck to identify human immunodeficiency virus (HIV) and Hepatitis C antiviral drugs. The company said in a press release that under terms of the agreement, DuPont M
Reuters NewMedia, Inc.; Friday, January 09, 1998 16:00:00
SAN FRANCISCO (Reuters) - The U.S. Department of Justice filed lawsuits Friday in a bid to shut down six California marijuana distribution clubs on the grounds they violated federal drug laws. The civil lawsuits, filed in federal courts in San Francisco and San Jose, marked the latest legal skirmish to rise from Califo
Reuters NewMedia, Inc.; Friday January 9, 7:47 am EST
DURHAM, N.C., Jan 9 (Reuters) - Trimeris Inc (Nasdaq:TRMS - news) said Friday it had initiated a Phase II clinical trial for T-20, a new class of anti-viral drugs that blocks HIV infection. The study will determine both the optimal dosing for T-20 and the feasibility of its administration through an infusion device dev
Reuters NewMedia, Inc.; Thursday January 8, 4:45 pm EST
NEW YORK, Jan 8 (Reuters) - Researchers have found that a natural component of human saliva can block the growth of laboratory strains of the virus that causes AIDS, New York Hospital-Cornell Medical Center said on Thursday. It said the finding, published in the Jan. 5 issue of the Journal of Experimental Medicine, cou
Reuters NewMedia, Inc.; Tuesday January 6, 4:12 pm EST
HAVANA, Jan 6 (Reuters) - Senior Cuban health officials said on Tuesday the rate of people being infected with the HIV virus that causes AIDS increased last year, although the island still had a low rate of infection. Deputy health minister Raul Perez Gonzalez and the ministry s director of epidemiology Manuel Santin t
This information is designed to support, not replace, the relationship that exists between you and your doctor.